Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Receivables (2020 - 2022)

Avai Bio's Receivables history spans 3 years, with the latest figure at $64444.0 for Q4 2022.

  • On a quarterly basis, Receivables changed N/A to $64444.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $64444.0, a N/A change, with the full-year FY2022 number at $3765.0, down 94.08% from a year prior.
  • Receivables hit $64444.0 in Q4 2022 for Avai Bio, up from $6644.0 in the prior quarter.
  • Over the last five years, Receivables for AVAI hit a ceiling of $204839.0 in Q3 2020 and a floor of $3765.0 in Q1 2022.
  • Historically, Receivables has averaged $60182.8 across 3 years, with a median of $47151.0 in 2020.
  • Biggest five-year swings in Receivables: surged 107.44% in 2021 and later plummeted 94.08% in 2022.
  • Tracing AVAI's Receivables over 3 years: stood at $204839.0 in 2020, then plummeted by 68.94% to $63629.0 in 2021, then increased by 1.28% to $64444.0 in 2022.
  • Business Quant data shows Receivables for AVAI at $64444.0 in Q4 2022, $6644.0 in Q3 2022, and $13828.0 in Q2 2022.